Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer. Heylen E, Verstraete P, Van Aerschot L, Geeraerts SL, et al. Br J Cancer 2023;128:1862-1878.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Heylen E, Verstraete P, Van Aerschot L, Geeraerts SL, et al. Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer. Br J Cancer 2023;128:1862-1878.
PMID: 36932191